AcuraBio Pty Ltd is one of Australia’s most experienced microbial fermentation CDMOs (including microbial recombinant proteins), offering trusted, client-focused services to both domestic and international clients for the past 20 years.
World-class researchers and proven facilities, a streamlined regulatory framework, generous tax incentives, and government funding make Australia a prime location for biotech research.
Leveraging decades of expertise in microbial expression systems, AcuraBio is now adding cGMP pDNA services to its service offering, offering plasmid DNA for therapeutic, vaccine and diagnostic applications including mRNA and viral vector based advanced therapies.
AcuraBio holds the following licenses: TGA (Australian FDA equivalent) license for the manufacture of human therapeutic APIs, APVMA (veterinary equivalent of the TGA) license for manufacture of sterile immunobiological products, OGTR license to produce products from genetically modified organisms (GMOs), and a DAF facility license for import and use of biologic materials.
Additional information about AcuraBio is available at www.acurabio.com.